Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The haemophilia certification system in Canada.

Literature DB >> 24922284

The haemophilia certification system in Canada.

Davide Matino¹, Jerry Teitel², David Page³, Arun Keepanasseril¹, Alfonso Iorio⁴, Irwin Walker⁵.

Abstract

Entities: Disease

Mesh：

Year: 2014 PMID： 24922284 PMCID： PMC4044813 DOI： 10.2450/2014.0032-14s

Source DB: PubMed Journal: Blood Transfus ISSN： 1723-2007 Impact factor: 3.443

× No keyword cloud information.

10 in total

1. The principal results of the International Immune Tolerance Study: a randomized dose comparison.

Authors: Charles R M Hay; Donna M DiMichele
Journal: Blood Date: 2011-11-18 Impact factor: 22.113

2. Treatment of haemophilia: building on strength in the third millennium.

Authors: P M Mannucci
Journal: Haemophilia Date: 2011-11 Impact factor: 4.287

Review 3. Recombinant Factor VIIa concentrate versus plasma derived concentrates for the treatment of acute bleeding episodes in people with haemophilia and inhibitors.

Authors: Alfonso Iorio; Davide Matino; Roberto D'Amico; Michael Makris
Journal: Cochrane Database Syst Rev Date: 2010-08-04

4. Mortality and causes of death in Italian persons with haemophilia, 1990-2007.

Authors: A Tagliaferri; G F Rivolta; A Iorio; E Oliovecchio; M E Mancuso; M Morfini; A Rocino; M G Mazzucconi; M Franchini; N Ciavarella; A Scaraggi; L Valdrè; G Tagariello; P Radossi; G Muleo; P G Iannaccaro; C Biasoli; D Vincenzi; M L Serino; S Linari; C Molinari; E Boeri; M La Pecorella; M T Carloni; E Santagostino; G Di Minno; A Coppola; A Rocino; E Zanon; L Spiezia; C Di Perna; M Marchesini; M Marcucci; A Dragani; S Macchi; P Albertini; M D'Incà; C Santoro; F Biondo; G Piseddu; G Rossetti; G Barillari; G Gandini; A C Giuffrida; G Castaman
Journal: Haemophilia Date: 2010-02-09 Impact factor: 4.287

Review 5. Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B.

Authors: Alfonso Iorio; Emanuela Marchesini; Maura Marcucci; Kent Stobart; Anthony Kc Chan
Journal: Cochrane Database Syst Rev Date: 2011-09-07

Review 6. Inherited abnormalities of coagulation: hemophilia, von Willebrand disease, and beyond.

Authors: Riten Kumar; Manuel Carcao
Journal: Pediatr Clin North Am Date: 2013-12 Impact factor: 3.278

7. Causes of death in Canadians with haemophilia 1980-1995. Association of Hemophilia Clinic Directors of Canada.

Authors: I R Walker; J A Julian
Journal: Haemophilia Date: 1998-09 Impact factor: 4.287

8. Blood safety monitoring among persons with bleeding disorders--United States, May 1998-June 2002.

Authors:
Journal: MMWR Morb Mortal Wkly Rep Date: 2003-01-03 Impact factor: 17.586

Review 9. von Willebrand disease: advances in pathogenetic understanding, diagnosis, and therapy.

Authors: David Lillicrap
Journal: Blood Date: 2013-09-24 Impact factor: 22.113

10. Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV.

Authors: Sarah C Darby; Sau Wan Kan; Rosemary J Spooner; Paul L F Giangrande; Frank G H Hill; Charles R M Hay; Christine A Lee; Christopher A Ludlam; Michael Williams
Journal: Blood Date: 2007-04-19 Impact factor: 22.113